Yu H - Search Results

1

Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer.

Merritt MA, Strickler HD, Hutson AD, Einstein MH, Rohan TE, Xue X, Sherman ME, Brinton LA, Yu H, Miller DS, Ramirez NC, Lankes HA, Birrer MJ, Huang GS, Gunter MJ. Merritt MA, et al. Among authors: yu h. Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):719-726. doi: 10.1158/1055-9965.EPI-20-1613. Epub 2021 Feb 23. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 33622671 Free PMC article.

2

Insulin-like growth factors and breast cancer risk in Chinese women.

Yu H, Jin F, Shu XO, Li BD, Dai Q, Cheng JR, Berkel HJ, Zheng W. Yu H, et al. Cancer Epidemiol Biomarkers Prev. 2002 Aug;11(8):705-12. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12163322

3

Joint effect of insulin-like growth factors and sex steroids on breast cancer risk.

Yu H, Shu XO, Li BD, Dai Q, Gao YT, Jin F, Zheng W. Yu H, et al. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):1067-73. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 14578144

4

Short tandem repeat polymorphism and cancer risk: influence of laboratory analysis on epidemiologic findings.

Tran N, Bharaj BS, Diamandis EP, Smith M, Li BD, Yu H. Tran N, et al. Among authors: yu h. Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2133-40. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15598771

5

The relationship of insulin-like growth factor-II, insulin-like growth factor binding protein-3, and estrogen receptor-alpha expression to disease progression in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Risch HA, Puopolo M, Yu H. Lu L, et al. Among authors: yu h. Clin Cancer Res. 2006 Feb 15;12(4):1208-14. doi: 10.1158/1078-0432.CCR-05-1801. Clin Cancer Res. 2006. PMID: 16489075

6

Specimen processing time and measurement of total insulin-like growth factor-I (IGF-I), free IGF-I, and IGF binding protein-3 (IGFBP-3).

Harris TG, Strickler HD, Yu H, Pollak MN, Monrad ES, Travin MI, Xue X, Rohan TE, Kaplan RC. Harris TG, et al. Among authors: yu h. Growth Horm IGF Res. 2006 Apr;16(2):86-92. doi: 10.1016/j.ghir.2006.01.002. Epub 2006 Mar 10. Growth Horm IGF Res. 2006. PMID: 16530441 Clinical Trial.

7

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Schwartz P, Yu H. Lu L, et al. Among authors: yu h. Gynecol Oncol. 2006 Dec;103(3):990-5. doi: 10.1016/j.ygyno.2006.06.006. Epub 2006 Jul 21. Gynecol Oncol. 2006. PMID: 16859738

8

Insulin resistance-related gene polymorphisms and risk of prostate cancer.

Moore SC, Leitzmann MF, Weinstein SJ, Snyder K, Albanes D, Virtamo J, Graubard BI, Mayne ST, Yu H, Peters U, Gunter MJ. Moore SC, et al. Among authors: yu h. Cancer Epidemiol Biomarkers Prev. 2007 Jun;16(6):1315-7. doi: 10.1158/1055-9965.EPI-07-0191. Cancer Epidemiol Biomarkers Prev. 2007. PMID: 17548707 Free article. Clinical Trial. No abstract available.

9

Expression of MDR1 in epithelial ovarian cancer and its association with disease progression.

Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H. Lu L, et al. Among authors: yu h. Oncol Res. 2007;16(8):395-403. doi: 10.3727/000000006783980892. Oncol Res. 2007. PMID: 17913048

10

Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.

Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H. Lu L, et al. Among authors: yu h. Cancer Res. 2007 Nov 1;67(21):10117-22. doi: 10.1158/0008-5472.CAN-07-2544. Cancer Res. 2007. PMID: 17974952

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

36,788 results

Search Page